LAUSR

Omidenepag Isopropyl Versus Latanoprost in Primary Open-angle Glaucoma and Ocular Hypertension: ThePhase 3 AYAME Study.

Sign Up to like & get
recommendations!
0 Published in 2020 at "American journal of ophthalmology"

DOI: 10.1016/j.ajo.2020.06.003

Abstract: PURPOSE To evaluate the efficacy and safety of omidenepag isopropyl (OMDI), a selective, non-prostaglandin, prostanoid EP2 receptor agonist, in Japanese patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT). DESIGN Phase 3, randomized, investigator-masked,… read more here.

Keywords: omidenepag isopropyl; versus latanoprost; versus; iop ... See more keywords